{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:12Z","timestamp":1794047472420,"version":"4.8.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1136\/ard.2008.092163","type":"journal-article","created":{"date-parts":[[2008,8,6]],"date-time":"2008-08-06T20:34:04Z","timestamp":1218054844000},"page":"1119-1124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":535,"title":["Dose-related patterns of glucocorticoid-induced side effects"],"prefix":"10.1016","volume":"68","author":[{"given":"D","family":"Huscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Gromnica-Ihle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Hein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Demary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Dreher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Zink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Buttgereit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2008.092163_bib1","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1002\/art.20583","article-title":"Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action","volume":"50","author":"Buttgereit","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092163_bib2","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.092163_bib3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(05)17989-6","article-title":"Optimised glucocorticoid therapy: the sharpening of an old spear","volume":"365","author":"Buttgereit","year":"2005","journal-title":"Lancet"},{"key":"10.1136\/ard.2008.092163_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Schacke","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1136\/ard.2008.092163_bib5","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/art.21467","article-title":"Current use of glucocorticoids in patients with rheumatoid arthritis in Germany","volume":"53","author":"Thiele","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092163_bib6","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1136\/ard.2007.072157","article-title":"EULAR evidence based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases","volume":"66","author":"Hoes","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.092163_bib7","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/ard.61.8.718","article-title":"Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology","volume":"61","author":"Buttgereit","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.092163_bib8","series-title":"Clinical immunology","article-title":"Glucocorticoids","author":"Buttgereit","year":"2008"},{"key":"10.1136\/ard.2008.092163_bib9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/art.21984","article-title":"Population-based assessment of adverse events associated with long-term glucocorticoid use","volume":"55","author":"Curtis","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092163_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092163_bib11","first-page":"144","article-title":"[Comparative evaluation of a German version of the Health Assessment Questionnaire and the Hannover Functional Capacity Questionnaire]","volume":"56","author":"Lautenschlaeger","year":"1997","journal-title":"Z Rheumatol"},{"key":"10.1136\/ard.2008.092163_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/ard.60.3.199","article-title":"The National Database of the German Collaborative Arthritis Centres. Structure, aims, and patients","volume":"60","author":"Zink","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.092163_bib13","first-page":"22","article-title":"Longterm studies in rheumatoid arthritis\u2014the German experience","volume":"69","author":"Zink","year":"2004","journal-title":"J Rheumatol Suppl"},{"key":"10.1136\/ard.2008.092163_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/ard.60.3.207","article-title":"The National Database of the German Collaborative Arthritis Centres\u2014treatment of patients with rheumatoid arthritis","volume":"60","author":"Zink","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.092163_bib15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/ncprheum0343","article-title":"Risks of glucocorticoid treatment\u2014are they related to treatment duration and dosage? Commentary","volume":"2","author":"Kavanaugh","year":"2006","journal-title":"Nat Clin Practice Rheumatol"},{"key":"10.1136\/ard.2008.092163_bib16","series-title":"Principles of corticosteroid therapy","first-page":"166","article-title":"Corticosteroids and the integument","author":"Wolverton","year":"2002"},{"key":"10.1136\/ard.2008.092163_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1378\/chest.48.3.287","article-title":"Long term (five or more years) administration of corticosteroids in pulmonary diseases","volume":"48","author":"Shubin","year":"1965","journal-title":"Dis Chest"},{"key":"10.1136\/ard.2008.092163_bib18","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/rheumatology\/37.9.930","article-title":"Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group","volume":"37","author":"Hickling","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2008.092163_bib19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/ard.2003.014050","article-title":"Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial","volume":"63","author":"Capell","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1136\/ard.2008.092163_bib20","doi-asserted-by":"crossref","first-page":"II\/90","DOI":"10.1007\/s003930070026","article-title":"Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis\u2014preliminary results of a multicenter, randomized, parallel, double blind study","volume":"59","author":"Rau","year":"2000","journal-title":"Z Rheumatol"},{"key":"10.1136\/ard.2008.092163_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-136-1-200201010-00006","article-title":"Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial","volume":"136","author":"van Everdingen","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2008.092163_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/ard.2005.038638","article-title":"Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data","volume":"65","author":"da Silva","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.092163_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0738-081X(86)90020-9","article-title":"Adverse effects of corticosteroids: II. Systemic","volume":"4","author":"Davis","year":"1986","journal-title":"Clin Dermatol"},{"key":"10.1136\/ard.2008.092163_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-0172(91)90051-Z","article-title":"The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis","volume":"21","author":"Caldwell","year":"1991","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2008.092163_bib25","first-page":"213","article-title":"[Polymyalgia rheumatica and giant cell arteritis; diagnosis and side effects of low-dose long-term glucocorticoid therapy]","volume":"51","author":"Hatz","year":"1992","journal-title":"Z Rheumatol"},{"key":"10.1136\/ard.2008.092163_bib26","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/ki.1987.131","article-title":"Mechanisms of glucocorticoid induced hypertension","volume":"31","author":"Whitworth","year":"1987","journal-title":"Kidney Int"},{"key":"10.1136\/ard.2008.092163_bib27","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1002\/art.21421","article-title":"Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial","volume":"52","author":"Wassenberg","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092163_bib28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199507203330302","article-title":"The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group","volume":"333","author":"Kirwan","year":"1995","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1136\/ard.2008.092163_bib29","doi-asserted-by":"crossref","first-page":"381s","DOI":"10.1042\/cs061381s","article-title":"Does long-term low-dose corticosteroid therapy cause hypertension?","volume":"61","author":"Jackson","year":"1981","journal-title":"Clin Sci (Lond)"},{"key":"10.1136\/ard.2008.092163_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rdc.2004.10.003","article-title":"Developments in glucocorticoid therapy","volume":"31","author":"Bijlsma","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.2008.092163_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0002-9343(94)90131-7","article-title":"Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events","volume":"96","author":"Saag","year":"1994","journal-title":"Am J Med"},{"key":"10.1136\/ard.2008.092163_bib32","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672421712X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672421712X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2008.092163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T20:37:36Z","timestamp":1737232656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672421712X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S000349672421712X"],"URL":"https:\/\/doi.org\/10.1136\/ard.2008.092163","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-related patterns of glucocorticoid-induced side effects","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2008.092163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 2009 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}